Oracle Launches AI Data Platform for Life Sciences Research

Feb 2, 2026
Oracle has introduced the Oracle Life Sciences AI Data Platform, a generative AI-enabled solution designed to unify and analyze large-scale health data to support pharmaceutical, medical device, and research organizations.

Oracle announced in a press release the launch of its Oracle Life Sciences AI Data Platform, a generative AI-driven analytics solution aimed at accelerating research and development, clinical trials, and commercialization for pharmaceutical, medical device, and life sciences organizations.

The platform combines proprietary and third-party data with more than 129 million de-identified longitudinal records from Oracle Health Real-World Data. It uses generative AI and agentic reasoning to interpret information and deliver actionable insights within research and clinical workflows.

Organizations can use built-in AI agents or create their own to perform tasks such as identifying label expansion opportunities, conducting Health Economics and Outcomes Research, generating synthetic control arms, and monitoring safety data. The system also allows researchers to ask open-ended questions, refine hypotheses, and track data lineage.

The platform integrates with Oracle Cloud Infrastructure, Oracle Life Sciences AI Application Suite, Oracle Fusion Cloud SCM, Oracle Fusion Cloud Sales, and Oracle Health AI Application Suite, providing a unified environment for life sciences operations. Oracle Corporation will showcase the platform at the SCOPE conference in Orlando, Florida, from February 2–5, 2026.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.